Detalhe da pesquisa
1.
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.
J Infect Dis;
219(8): 1187-1197, 2019 04 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30407513
2.
Vaccination coverage and immunization timeliness among children aged 12-23 months in Senegal: a Kaplan-Meier and Cox regression analysis approach.
Pan Afr Med J;
27(Suppl 3): 8, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29296143
3.
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.
Lancet Respir Med;
3(3): 190-200, 2015 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25726088
4.
Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4.
J Acquir Immune Defic Syndr;
58(4): e103-11, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21909029